Human IL-13 Alexa Fluor® 750-conjugated Antibody
Human IL-13 Alexa Fluor® 750-conjugated Antibody Summary
Accession # P35225
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Preparation and Storage
IL-13 is a 17 kDa immunoregulatory cytokine that plays a key role in the pathogenesis of allergic asthma and atopy. It is secreted by Th1 and Th2 CD4+ T cells, NK cells, visceral smooth muscle cells, eosinophils, mast cells, and basophils (1-3). IL-13 circulates as a monomer with two internal disulfide bonds that contribute to a bundled four alpha -helix configuration (4, 5). Mature human IL-13 shares 57%, 59%, and 94% amino acid sequence identity with mouse, rat, and rhesus IL-13, respectively. Despite the low homology, it exhibits cross-species activity between human, mouse, and rat (6, 7). IL-13 has diverse activities on numerous cell types (8). On macrophages, IL-13 suppresses the production of proinflammatory cytokines and other cytotoxic substances. On B cells, IL-13 induces immunoglobulin class switching to IgE, upregulates the expression of MHC class II, CD71, CD72, and CD23, and costimulates proliferation. IL-13 upregulates IL-6 while downregulating IL-1 and TNF-alpha production by fibroblasts and endothelial cells. IL-13 binds with low affinity to IL-13 R alpha 1, triggering IL-13 R alpha 1 association with IL-4 R alpha. This high affinity receptor complex also functions as the type 2 IL-4 receptor complex (9, 10). Additionally, IL-13 binds with high affinity to IL-13 R alpha 2 which is expressed intracellularly, on the cell surface, and as a soluble molecule (11-14). IL-13 R alpha 2 regulates the bioavailability of both IL-13 and IL-4 and is over-expressed in glioma and several bronchial pathologies (10, 15, 16). Compared to wild type IL-13, the atopy-associated R110Q variant of IL-13 elicits increased responsiveness from eosinophils that express low levels of IL-13 R alpha 2 (17).
- Wills-Karp, M. (2004) Immunol. Rev. 202:175.
- Nakajima H. and K. Takatsu (2007) Int. Arch. Allergy Immunol. 142:265.
- McKenzie, A.N. et al. (1993) Proc. Natl. Acad. Sci. USA 90:3735.
- Moy, F.J. et al. (2001) J. Mol. Biol. 310:219.
- Eisenmesser, E.Z. et al. (2001) J. Mol. Biol. 310:231.
- Ruetten, H. and C. Thiemermann (1997) Shock 8:409.
- Lakkis, F.G. et al. (1997) Biochem. Biophys. Res. Commun. 235:529.
- Wynn, T.A. (2003) Annu. Rev. Immunol. 21:425.
- Andrews, A.L. et al. (2002) J. Biol. Chem. 277:46073.
- Tabata, Y. et al. (2007) Curr. Allergy Asthma Rep. 7:338.
- Chiaramonte, M.G. et al. (2003) J. Exp. Med. 197:687.
- Daines, M.O. and G.K. Hershey (2002) J. Biol. Chem. 227:10387.
- Matsumura, M. et al. (2007) Biochem. Biophys. Res. Commun. 360:464.
- Tabata, Y. et al. (2007) J. Immunol. 177:7905.
- Andrews, A.L. et al. (2006) J. Allergy Clin. Immunol. 118:858.
- Joshi, B.H. et al. (2006) Vitam. Horm. 74:479.
- Andrews, A-L. et al. (2007) J. Allergy Clin. Immunol. 120:91.
Product Specific Notices
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
No product specific FAQs exist for this product, however you mayView all Antibody FAQs
Reviews for Human IL-13 Alexa Fluor® 750-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human IL-13 Alexa Fluor® 750-conjugated Antibody and earn rewards!
Have you used Human IL-13 Alexa Fluor® 750-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image